Clinical trial sponsors and CROs don’t need to imagine South Korea as a country of limitless potential, they know it is. South Korea is a clinical trial destination with world-class medical infrastructure, a highly-educated, relatively wealthy and healthy population. Their investigators are, on the whole, actively engaged in clinical trials and keen to play their […]
Read More
As the world stops to celebrate and reflect on International Women’s Day on the 8th of March, George Clinical is proud to play their part in #beboldforchange. Traditionally the commercial research sector has a larger proportion of female practitioners than men. Indeed, at George Clinical, the proportion female to men at 158:73 and with a […]
Read More
George Clinical is pleased to announce the continued expansion of their Business Development operations in the US, with the recent appointments of Mindy Farr as Senior Business Development Manager and Kristina Figueroa, Business Development Manager. “Both Mindy and Kristina are joining George Clinical at an exciting time in the organisation’s history”, Mr Clark said. “We […]
Read MoreVideo Transcript Congratulations on The Google Impact Challenge win. Can you explain what TEXTCARE does and what issue it addresses? 0:07 – 3:09 It is really exciting; I think we’re all a little bit stunned still, although I feel that we did have a fabulous proposal and it’s very exciting to think that we will […]
Read More
The face of individual health care is changing and improving, thanks to wearables. Wearable health and fitness devices are becoming more popular by the day and with our mobile devices and wearables prompting us to keep up with good health habits, overall health is improving too. As individuals are more aware of their health, more […]
Read More
With the New Year comes new innovations in technology. Many new technological innovations were just announced and launched at the Consumer Electronics Show (CES) in Las Vegas earlier this month. Normally this is not big news for the healthcare industry, or in the area of clinical trials, but this year was an exception. Some very […]
Read More
Increasingly, regulatory authorities are placing significant focus on clinical trial processes that ensure consistent, standardized, objective and unbiased reporting of safety and efficacy results; given that the definitions for many endpoint events include subjective components, and investigator-to-investigator subjective assessments may differ. Moreover, an increasing number of trials are now conducted in multiple geographies, and clinical […]
Read More
In the world of healthcare, time is always of the essence. Researchers are continuously looking for new solutions to help improve patients’ well-being and ultimately save lives. The discovery process of new treatments takes an enormous amount of time and resources in order to generate good evidence to prove that they are safe and that […]
Read More
A key step in developing a new drug is the transition from the laboratory to the human subject in a Phase I clinical trial, where the new compound is given to humans for the first time. A Phase I trial is the gateway between scientific research and clinical medicine. Generally, in-human Phase I studies are […]
Read More
Thrombolysis will continue to be the mainstay for acute stroke treatment, despite the recent revolution in neurointerventional clot retrieval. However, as there are ongoing limitations of thrombolysis of bleeding risk and reduced efficacy in large clots – what possible therapeutic advancements can complement or act as an adjuvant to thrombolysis? Neurointervention – effective, but limited […]
Read More
